ClinicalTrials.gg

Program

Lubricant Eye Drops

Also written as “Artificial Tear”, “Lubricant Eye Drops (Optive™)” and “Lubricating Eye Drops (blink® Tears)”.

Its studies are mostly in Keratoconjunctivitis Sicca · Dry Eye Syndromes · Inflammation, led by 2 companies.

Furthest: phase 4, since Sep 18, 20083 company-led studies, 1 open or runningNext primary completion: Nov 2026 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
AbbVie20 open or runningphase 4since Sep 18, 2008Sep 18, 2008none ahead
BRIM Biotechnology11 open or runningphase 2since Jul 14, 2025Jul 14, 2025Nov 2026phase 2 · NCT07078955

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 18, 2008First study: phase 4 study in Dry Eye SyndromesNew to AbbVieAbbVie · NCT00756678 · 51 enrolled · United States
  2. Nov 12, 2008Phase 4 study in InflammationAbbVie · NCT00791323 · 9 enrolled · United States
  3. Jul 14, 2025BRIM Biotechnology's first study: phase 2 study in Dry Eye SyndromesNew to BRIM BiotechnologyBRIM Biotechnology · NCT07078955 · 99 planned · Taiwan

Ahead

  1. Nov 2026Primary completion: phase 2 study in Dry Eye SyndromesBRIM Biotechnology · NCT07078955

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07078955Dry Eye Syndromes · Taiwan2Not yet recruitingBRIM BiotechnologyNov 202699
NCT00791323Inflammation · United States4CompletedAbbVieAug 20099
NCT00756678Dry Eye Syndromes · United States4CompletedAbbVieAug 200951

How it is read

Names in the registry

  • “Artificial Tear”, 1 entry
  • “Lubricant Eye Drops (Optive™)”, 1 entry
  • “Lubricating Eye Drops (blink® Tears)”, 1 entry
  • “Lubricating Eye Drop”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
Lubricant Eye Drops (AbbVie): development program | ClinicalTrials.gg